Compounds > 6-anilino-5,8-quinolinedione
Page last updated: 2024-10-30

6-anilino-5,8-quinolinedione and Idiopathic Parkinson Disease

6-anilino-5,8-quinolinedione has been researched along with Idiopathic Parkinson Disease in 1 studies

6-anilino-5,8-quinolinedione: structure given in first source; SRS-A & guanylate cyclase antagonist
6-anilino-5,8-quinolinedione : A quinolone that is quinoline-5,8-dione in which the hydrogen at position 6 is replaced by an anilino group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Canals, S1
Casarejos, MJ1
de Bernardo, S1
Rodríguez-Martín, E1
Mena, MA1

Other Studies

1 other study available for 6-anilino-5,8-quinolinedione and Idiopathic Parkinson Disease

ArticleYear
Glutathione depletion switches nitric oxide neurotrophic effects to cell death in midbrain cultures: implications for Parkinson's disease.
    Journal of neurochemistry, 2001, Volume: 79, Issue:6

    Topics: Alkaloids; Aminoquinolines; Animals; Antioxidants; Apoptosis; Ascorbic Acid; Buthionine Sulfoximine;

2001